Abstract:Liposomes can increase plasma half-life, enhance targeting, and diminish the side-effects of loaded drugs. On the downside, physical and chemical instabilities of dispersions often result in a reduced lifespan, which limits their availability on the market. Solid formulations obtained by freeze-drying can immobilize vesicles and provide extended shelf life. For both processes, the choice of excipients and process parameters are crucial to protect the carrier layers against tension caused by freezing and/or dehydration. The aim of this work is to evaluate the influence of freezing and drying parameters, besides excipient choice, to obtain solid long-circulating and fusogenic liposomes (LCFL-PTX/DXR) co-encapsulating paclitaxel (PTX) and doxorubicin (DXR) at a synergistic ratio (1:10). Methods: LCFL-PTX/DXR was evaluated by freeze-drying microscopy (glass transition, Tg'), differential scanning calorimetry (collapse temperature, Tc), freeze-thawing and freeze-drying processes. Freeze-dried samples were evaluated by thermogravimetry (residual moisture) and the resuspended liposomes were characterized in terms of size, polydispersity index (PI), zeta potential (ZP), and drug content. Liposomes morphology was evaluated by cryomicroscopy. Results: Trehalose protected PTX cargo upon freeze-thawing and more than 80% of the original DXR retention. The formulations with trehalose resulted in a cake with 5-7% of moisture content (200-240 nm); 44-60% of PTX retention, and 25-35% of DXR retention, with the variations caused by cryoprotector concentration and process changes. Conclusions: Trehalose protected liposome integrity, maintaining PTX retention and most of DXR upon freeze-thawing. Freeze-drying reduced the retention of both drugs inside all liposomes, whereas formulation with trehalose presented minor losses. Therefore, this frozen formulation is an alternative product option, with no need for manipulation before use.

Freeze-drying of Liposomal Nanohybrid Cerasomes with Cryoprotectants: in Vitro and in Vivo Evaluation

Preparation and Characterization of Nanoliposomes Entrapping Medium-Chain Fatty Acids and Vitamin C by Lyophilization

Safety evaluation of liposomal nanohybrid cerasomes and their application in the release of 10-hydroxycamptothecin

Freeze Drying of Polymer Nanoparticles and Liposomes Exploiting Different Saccharide-Based Approaches

Stabilized Liposomal Nanohybrid Cerasomes for Drug Delivery Applications

Cerasomal doxorubicin with long-term storage stability and controllable sustained release

Freeze-drying of liposomes with cryoprotectants and its effect on retention rate of encapsulated ftorafur and vitamin A

Improvement of Thermosensitive Liposome Stability by Cerasome Forming Lipid with Si-O-Si Network Structure

The Effects of Cryoprotectants on the Freeze-Drying of Ibuprofen-Loaded Solid Lipid Microparticles (Slm)

Recent advances in liposomal nanohybrid cerasomes as promising drug nanocarriers.

Efficient Energy Transfer and Controlled Drug Release in Highly Stable Novel Nanoliposomes

Preserving the Integrity of Liposomes Prepared by Ethanol Injection upon Freeze-Drying: Insights from Combined Molecular Dynamics Simulations and Experimental Data

Hybrid nanospheres and vesicles based on pectin as drug carriers.

Lyophilizable Stem Cell‐Hybrid Liposome with Long‐Term Stability and High Targeting Capacity

Sugar-based Cryoprotectants Stabilize Liposomal Vesicles by Exhibiting a Cholesterol-like Effect

Readily Restoring Freeze-Dried Probilosomes As Potential Nanocarriers for Enhancing Oral Delivery of Cyclosporine A

Design and synthesis of lipidic organoalkoxysilanes for the self-assembly of liposomal nanohybrid cerasomes with controlled drug release properties.

Effect of cryoprotectants on the reconstitution of silica nanoparticles produced by sol–gel technology

Cryoprotection–lyophilization and physical stabilization of rifampicin-loaded flower-like polymeric micelles

Liposomal nanohybrid cerasomes for controlled insulin release

Long-Circulating and Fusogenic Liposomes Loaded with Paclitaxel and Doxorubicin: Effect of Excipient, Freezing, and Freeze-Drying on Quality Attributes